Dr. Carlos Rodrigo Camara-Lemarroy is an early-career researcher and clinical neurologist based in Canada at the University of Calgary. He is a first-time recipient of an ALS Canada-Brain Canada research grant.
Dr. Maria Stepanova, a physicist at the University of Alberta, is one of nine 2022 ALS Canada-Brain Canada Discovery Grant recipients. She works closely with Dr. Holger Wille, a structural biologist also at U of A. Though both have decades of experience researching other neurodegenerative diseases, the grant represents their first time being funded for ALS research.
When Dr. Thomas Durcan, director of The Neuro’s Early Drug Discovery Unit (EDDU), found out his team had been awarded a 2022 Discovery Grant, “It was a very happy day for us all.”
Dr. Richard Robitaille, at the Université de Montréal, received his first grant from ALS Canada ten years ago. Already a world-leading expert on the neuromuscular junction (NMJ), the funding was his first research foray into ALS and allowed him to find clinical applications for his expertise. His lab now spends nearly all their research efforts on the disease.
For years, interior designer Raija Hilska felt like she was “always dragging something along”. Deep melancholy, profound sadness, raw emotions and, sometimes, thoughts of suicide.
